RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
more
Stories about Health / Medicine
- Language:
- Media:
- Period:
- Period:Total
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
more- 25
The Future of Nutrition: Dr. Clemens Röhrl on Regional Plant Research and Its Importance for Health and the Environment
more Strides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
more- 2
SHL Medical announces plans to establish SHL Advantec
more RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
moreWort & Bild Verlagsgruppe - Unternehmensmeldungen
You.com and Wort & Bild Verlag Join Forces to Increase Health Information Access with AI
moreBosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
moreBosch Healthcare Solutions GmbH
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling point
moreFitLine becomes Official Partner of the ATP Tour
more- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more Virchow Foundation for Global Health
2Lucy Gilson and Johan Rockström awarded the Virchow Prize 2024
moreGerresheimer expands capacities for Medical Systems in the USA
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
moreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
moreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreSHL Medical partners with SteriPack Group to set up final assembly service
moreLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
moreSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
moreBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreSuperVista AG expands strategically with new 360-degree B2B offering for the entire ophthalmic optics sector
moreSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
moreOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developments
moreGerman Bionic Debuts Groundbreaking Power Suit for Nursing and Care Professionals in North America
morePatientGPT from Semalytix Will Replace Six Months of Evidence & Insight Generation in Life Science with Seconds
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreInnovative regeneration for handball players: Reboots becomes official supplier of the German Handball Federation
moreAustrian State Printing House (OSD)
2The Republic of Ghana Launches Nationwide Healthcare Digital App by OSD
more
1234Next